Relay Therapeutics (RLAY) Interest & Investment Income (2019 - 2026)
Relay Therapeutics (RLAY) reported Interest & Investment Income of $5.4 million for Q1 2026, down 31.5% year-over-year from $7.8 million in Q1 2025, and down 6.27% on a QoQ basis from $5.7 million in Q4 2025.
Relay Therapeutics (RLAY) has 8 years of Interest & Investment Income data on file, last reported at $5.4 million in Q1 2026.
- Quarterly Interest & Investment Income fell 31.5% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.6 million (down 26.88% YoY) and the FY2025 annual result came in at $27.0 million, down 22.19% from the prior year.
- Interest & Investment Income eased to $5.4 million in Q1 2026 per RLAY's latest filing, from $5.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $9.0 million in Q4 2024 and bottomed at $696000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $7.1 million (2025), against an average of $6.3 million.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 1911.99%; it then tumbled 36.37% in 2025.
- Tracing RLAY's Interest & Investment Income over 5 years: stood at $5.4 million in 2022, then surged by 61.95% to $8.7 million in 2023, then climbed by 3.15% to $9.0 million in 2024, then plunged by 36.37% to $5.7 million in 2025, then dropped by 6.27% to $5.4 million in 2026.
- Per Business Quant, the three latest RLAY Interest & Investment Income figures stand at $5.4 million (Q1 2026), $5.7 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Relay Therapeutics | 2.53 Bn | 2.53 Bn | - | 5.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.71 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 7.81 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | 8.27 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.95 Mn |
| Dec 31, 2023 | 8.70 Mn |
| Sep 30, 2023 | 7.85 Mn |
| Jun 30, 2023 | 7.56 Mn |
| Mar 31, 2023 | 6.94 Mn |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 696,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | 180,000.00 |
| Mar 31, 2021 | 226,000.00 |
| Dec 31, 2020 | 296,000.00 |
| Sep 30, 2020 | 534,000.00 |
| Jun 30, 2020 | 998,000.00 |
| Mar 31, 2020 | 1.57 Mn |
| Dec 31, 2019 | 1.92 Mn |
| Sep 30, 2019 | 2.24 Mn |
| Jun 30, 2019 | 2.37 Mn |